Alendronate Plus D3 70 mg/140 ug APOTEX alendronic acid (as sodium) 70 mg and colecalciferol 140 microgram tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

colecalciferol, Quantity: 140 microgram; alendronate sodium, Quantity: 91.37 mg

Disponível em:

Arrotex Pharmaceuticals Pty Ltd

DCI (Denominação Comum Internacional):

alendronate sodium,colecalciferol

Forma farmacêutica:

Tablet

Composição:

Excipient Ingredients: mannitol; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; butylated hydroxytoluene

Via de administração:

Oral

Unidades em pacote:

4

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Alendronate Plus D 70 mg/70 ?g and Alendronate Plus D 70 mg/140 ?g tablets are indicated for the treatment of:,Osteoporosis in select patients where vitamin D supplementation is recommended.,Prior to treatment, osteroporosis must be confirmed by:,The finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,The presence of osteoporotic fracture

Resumo do produto:

Visual Identification: White to off-white, rectangular, biconvex tablet. Engraved APO on one side, ALE-D56 on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2014-12-17